- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07850128
Risk of Cervical Cancer Following Incident, Persistent and History-unknown HPV Detection
Risk of Cervical Cancer Following Incident, Persistent and History-unknown Human Papillomavirus (HPV) Detection by HPV Genotype
The goal of this register-based retrospective observational study is to understand the risk of cervical cancer following incident, persistent and history-unknown HPV detection by HPV genotype in healthy women participating in HPV-based cervical screening. The main questions it aims to answer are:
- Whether an incident HPV detection with certain HPV genotypes has low risk of cervical cancer in 3 to 5 years thus does not need further clinical assessment before the next screening test?
- How risky a persistent HPV detection is, and whether persistent detection of any high-risk HPV genotype warrant immediate clinical assessment?
- How risky a HPV detection is, if no previous HPV test result is available?
As being a register-based retrospective observational study, study subjects will not be asked to do any specific task for this study.
연구 개요
상세 설명
This study includes all women in the study population (women at screening ages and living in the Stockholm region during 2014-2023) who had HPV positive test result(s) in the primary HPV screening. In 2014-2016, half of the screening population were randomised to primary HPV screening and the other half received cytology-based screening (NCT01511328). From 2017 onwards, all women received primary HPV screening. As data are retrieved from established registries which are already accessible to the researchers for previous and ongoing related research projects, the data collection time is almost negligible.
연구 유형
등록 (추정된)
연락처 및 위치
연구 연락처
- 이름: Jiangrong Wang, PhD
- 전화번호: +46769309451
- 이메일: jiangrong.wang@ki.se
연구 연락처 백업
- 이름: Joakim Dillner, PhD
- 이메일: joakim.dillner@ki.se
연구 장소
-
-
-
Stockholm, 스웨덴, 141 52
- 모병
- Centre for Cervical Cancer Elimination, Department of Clinical Science, Intervention and Technology, Karolinska Institutet
-
연락하다:
- Jiangrong Wang, PhD
- 전화번호: +46769309451
- 이메일: jiangrong.wang@ki.se
-
연락하다:
- 이메일: jiangrong.wang@ki.se
-
부수사관:
- Jiangrong Wang, PhD
-
수석 연구원:
- Joakim Dillner, PhD
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
샘플링 방법
연구 인구
Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in the primary HPV test during 2014-2023
설명
Inclusion Criteria:
- Women living in the Great Stockholm Region in Sweden, at cervical screening ages (age 22-70 years), and having had an HPV positive result in primary HPV test during 2014-2023
Exclusion Criteria:
- Women without valid personal identity number in the population registry
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 관찰 모델: COHORT
- 시간 관점: RETROSPECTIVE
코호트 및 개입
그룹/코호트 |
개입 / 치료 |
|---|---|
|
Incident HPV detection
The first HPV positive result in the primary HPV test, following an HPV negative test result in the previous primary HPV test |
All data will be retrieved retrospectively from registry data. |
|
Persistent HPV detection
The HPV positive result in the primary HPV test following an HPV positive test result with the same genotype in the previous primary HPV test |
All data will be retrieved retrospectively from registry data. |
|
History-unknown HPV detection
The first HPV positive result in the primary HPV test, without any primary HPV test record in the past |
All data will be retrieved retrospectively from registry data. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Diagnosis of invasive cervical cancer
기간: From HPV infection to the end of the study Dec 31st, 2024
|
Primary and invasive cervical cancer |
From HPV infection to the end of the study Dec 31st, 2024
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Precancerous lesion CIN2+ (Cervical Intraepithelial Neoplasia grade 2 and above)
기간: From HPV infection to the end of the study Dec 31st, 2024
|
CIN2, CIN3, Adenocarcinoma in situ |
From HPV infection to the end of the study Dec 31st, 2024
|
공동 작업자 및 조사자
간행물 및 유용한 링크
일반 간행물
- Bjorge T, Stoer NC, Hverven SK, Nygard M, Trope A, Engesaeter B. Risk of high-grade cervical lesions in the second round of primary human papillomavirus testing in CervicalScreen Norway: A population-based cohort study. Int J Cancer. 2025 Jul 15;157(2):251-259. doi: 10.1002/ijc.35359. Epub 2025 Feb 8.
- Wei F, Georges D, Man I, Baussano I, Clifford GM. Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature. Lancet. 2024 Aug 3;404(10451):435-444. doi: 10.1016/S0140-6736(24)01097-3.
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (실제)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- IPUHPV&CxCa
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
IPD will be derived from the Swedish National Cervical Screening Registry and the Swedish National Quality Register for Gynaecological Cancers. Data from these two registries can be shared upon application, provided that ethical approval is obtained.
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .